International Journal of Clinical Biochemistry and Research

Print ISSN: 2394-6369

Online ISSN: 2394-6377

CODEN : IJCBK6

International Journal of Clinical Biochemistry and Research (IJCBR) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award more...

  • Article highlights
  • Article tables
  • Article images

Article statistics

Viewed: 1134

PDF Downloaded: 567


Get Permission Kwadjo Anicet Luc, Ferdinand, Kahissié, André Bhellis, and Gnomblesson Georges: Incorporation and distribution of crude palm oil fatty acids in the plasmatic lipids of consumers


Introduction

The composition of our diet plays an important role in the steadying of our health and defines more or less its evolution. Nowadays, facing several a ssaults that we undergo and which affect our health, the best behaviour should be to act on those reflecting our lifestyle precisely diseases linked to inappropriate alimentation. Among different substrates brought by alimentation figure the fatty acids. Fats of our alimentation derive together from vegetal oils and animal fats. While animal fats bringing in majority satured fatty acids (SFA) and cholesterol, vegetal oils providing as well SFA as monounsatured fatty acids (MUFA) and polyunsatured fatty acids (PUFA).1,2

Among vegetal oils use in the world, palm oil is rating in a preferable position as well in the countries of West Africa, central Africa as in the countries of south-east Asia.3 Palm oil is a solid vegetal oil, rich in saturated fatty acids (50%), mainly in palmitic acid. Also, it contains 50 % of unsaturated fatty acids and its level in tocotrienols and carotenoids is important but partly altered by refin ing and heating. Epidemiological studies are unusual and of poor quality, so t hese data are discussed under the light on the actual concept based on the implication of saturated fatty acids in ca rdiovascular diseases.4 Thus, a frequent and excessive consumption of palm oil in our diet, through manufactured products, could be deleterious. Nonetheless the adverse effects of palm oil consumption are not well known. Despite its contents, there is a persistence of several controversies on the benefit effects of palm oil consumption related to its contain of satured fatty acids.3 Several studies conducted in Africa and in the world focused on the beneficial effects of palm oil consumption on the changes of biological parameters are available without bringing irrefutable evidence of it s action.5,6

Our research is a study of collective supplementation which is elaborated in a global frame of valorization of vegetal oils consumed in Côted'Ivoire. This study concerned the repartition of fatty acids of crude palm oil in the plasmatic lipids of consumers during a certain delay due to it wide use in West Africa and particularly in Côted'Ivoire.

Materials and Methods

Participants

It was an interventional essay related to collective supplementation. This study was focused on 30 participants apparently in good health including 1 5 women and 15 men. Were included in this study, black volunteers aged at least 25 years old and 45 years old at most, without any hepatic, metabolic, cardiovascular and infectious diseases. Weren’t included, obese participants, leans, smokers or alcoholics, likewise participants having a report of dyslipidemia, hyperuricemia or another metabolic disease. Each participant gave a lightened consent. The protocol was approved by the unit of training and research of medical sciences (Félix Houphouet-Boigny University), and had been explained to the participants before their approbation.

Confection of crude palm oil

Crude palm oil is usually use d in each household and that oil is artisanally extracted from palm seeds. Extraction is done after separating, cooking of seeds and pressing. Palm oil resulting is extracted by warm pressure of palm seeds, approximately 100 kg of fruits produce 22 kg of oil. This oil obtained is commercialized such as a native oil of red colour. Its rate of caretenoids augments the level of vitamin A, resistant to high temperatures and it is mostly use for cooking.

Protocol of experimentation

Experimentation lasted 15 days, during which, participants were private d of any consumption of fat food before and after the supplementation. Supplementation has been done during the lunch. The menu was made of a portion of rice with lean fish. Supplementation has been realized by addition of 70 grams of crude palm oil (7 soup spoons) in the rice after cooking. Every participant received this meal throughout the supplementation. Every participant had to go into the laboratory of medical biochemistry in the morning to undergo the venipuncture and at the lunch time to take the meal.

Blood collection

The blood samples have been picked prior to the onset of experimentation (J0) and then seven days after (J7) and finally after fifteen days (J 15). For all samples, participants had been fasting since the previous evening (10 to 12 hours). Blood has been collected by venipuncture and gathered into dry vacutainer® tubes. After five minutes of centrifugation (4000 r/min), the specimen has been separated into aliquots. Aliquots have been conserved at -20°C in our laboratory, before being forwarded in dry ice to Lapeyronie in France. Aliquots have been kept again at -20°C until the moment of analyzes.

Laboratory methods

Dosage of fatty acids was made by gas chromatography, equipped with a flame ionization detector and an injector, coupled to a digital integrator, after extraction of the fatty acids. Free fatty a cid methyl esters were measured according to the methods of Bondia et al.7 Results were expressed for each fatty acid as a percentage of total fatty acids.

Statistical analysis

Analyzes were performed using SPSS software version 3.11. The comparison of means was obtained by the student T-test. Results were expressed in means ± standard deviation. The level of significance of the tests used was set at α = 5%, difference was considered significant for P value < 0.0 5.

Results

Incorporation of SFA of palm oil increased throughout the supplementation in the different lipids fractions such as esterified cholesterol, phospholipids and triacyglycerols. Incorporation was significant in esterified cholesterol from (J0) 23.42 to (J15 ) 23.34 (Table 1). Inversely, we noted an absence of SFA’s incorporation in total lipids, marked by a reduction which was significant from J0 (34.53) to J15 (32.12). The rate of MUFA increased in the fraction of esterified cholesterol and total lipids during the assay. Increasing has been steady and significant for esterified cholesterol (J0) 33.48 to (J15) 34.55. However we registered a reduction of the rate of MUFA in phospholipids and triacylglycerols (Table 2 ).

Related to PUFA, we noted an absence of this trend in the fractions of esterified cholesterol, phospholipids together with in the triacylglycerols. The diminution of the rate of fatty acids in these fracti ons was significant for esterified cholesterol and triacylglyc erols. We also observed a discreet incrementation of fatty acids in total lipids (Table 2). Throughout the supplementation of palm oil, we noted a reduction of omega 6 incorporation in the different fractions, in contrary the rate of fatty acids increased during this period. Thus, the ratio of omega 6/omega 3 initially elevated for participants, diminished but stayed around 5 in most lipid fractions excepted phospholipids for which the level decreased down to 3.13 at the end of experimentation (Table 2).

Discussion

Fatty acids of crude palm oil are compounded of 45 – 55 % of SFA, 38- 45% of MUFA and 9-12% PUFA3,4,8 making it the most important vegetal oil rich in satured fatty acids. Among them, palmitic acid, oleic acid and linoleic acid are the SFA most presented in the crude palm oil. According to some authors, regular consumption of palm oil increases the risk of atherosclerosis because palm oil increases cholesterol levels, LDL-C levels and HDL-C.4,9 Refined palm oil, bleached and deodorized, although is the most vegetal oil commercialized and used in the manufactured industries owing to its chemical properties.10 Crude palm oil using in different households in Africa is artisanally extracted and resist to a warm temperature. Lately, some varieties of palm oil selected as part of a genetic crossover by the Ivorian National Center of Agronomic research (CNRA- Côte d ’ Ivoire) have been the su bject of scientific reports mentioning a new varieties of palm seed in which the rate of UFA and SFA are respectively of 48-60% and 40-52%.3,5

In their report, Voon et al.11 didn’t observe any difference related to the level of esterified cholesterol and triacylglycerol in a study regarding the effect between palm oil and olive oil. In contrast, others12,13 found an increasing level of total cholesterol, LDL -C and C-LDL/C-HDL ratio m ore importantly with food enrich in palm oil than those contain more PUFA. Vegetal oils rich in PUFA such as olive oil would have a favorable effect on the plasmatic lipids by decreasing the hepatic pro duction of VLDL, LDL and total cholesterol.9,14 Otherwise, the high level of UFA should increase the susceptibility of these oils to oxidation which would have justified their hydrogenation and the culture of others cultivars having a less risk of oxidation.5

A meta- analysis published in 2010 didn ’ t confirm a significant correlation between SFA and risk of cardiovascular diseases or cerebra vascular accidents.15 The link between the se diseases and SFA consumption would be submitted to several cofounding parameters explaining for partly the disparity in the findings of different studies. Only a few epidemiological studies tempted to take into consideration the role of palm oil on the risk of cardiovascular diseases.16,17,18

As for the most food enrich in SFA, palm oil increases the level of C-LDL together with the C-HDL,4,19 due to its permanent consumption containing palmitic and oleic acid.9,11,20 Its high level in oleic acid represents therefore a beneficial effect because more of 85% of SFA located in Sn-2 are unsatured and means that the SFA are in peripheral positions Sn-1 and Sn-3 and thus less available.10 The intake of crude palm oil triggered an augmentation of PUFA concentration and in particular the fraction of fatty acids omega3 in all different lipid fractions. This trend reveals the benefit effect of the daily consumption of crude palm oil in our ali mentation. In fact, amongst PUFA, essential fatty acids are necessary for maintaining homeostasis, thus we have to integrate vegetal oil in our diet.18 The essential fatty acids play an important role in the good work of different systems such as neuronal, cardiovascular and immunology.21 The ω -6/ ω -3 ratio throughout the supplementation downed from 7.06 (J0 ) to 5.60 (J15). Crude palm oil should be relevant for household use according to European recommendations which stipulated that this ratio would not exceed five. 22

In a multivariable model, insulin and HOMA-IR were positively associated with the dietary ω-6/ω-3 PUFA ratio. In vivo, some studies showed that mice fed up with a high dietary ω-6/ω-3 PUFA ratio got higher levels of triglycerides in comparison with those fed up with lower ratio.23 Otherwise, when rats were fed up with a diet with low ω-6/ω -3 PUFA ratio, the level of glucose and insulin were improved; moreover, in some cases these changes were accompanied by a lower level of pro-inflammatory cytokines.24 In the human’s case, those who receive d a supplementation with ω-3 PUFAs, the arachidonic Acid/eicosapentanoic Acid ratio decreased, and this change was accompanied by a reduction of triacylglycerol level for the participants.25 A dditionally, crude palm oil is an important source of natural compounds and carry an important amount of polyphenolic that could reduce the activities of the free radical.26 This oil widely consumed in Africa, presents many advantages as well economic, nutritional as health benefit because the high level of MUFA down s the level of LDL-cholesterol while maintaining HDL-concentration.27 Moreover, due to its high concentration of antioxidants, palm oil has got a long delay of conservation rather than the others nutritive vegetal oils and which makes it particularly resistant to rancidity.

These two latest beneficial effects of palm oil in the prevention of any cardiovascular diseases regardless the adverse consequences linked to high concentration of SFA derived from vegetal oil, could motivated its prescription such as a support of medical treatment in some cases. But, we have to hearten and stand the entire endeavour carried out by the Ivorian Center of Research in Agronomy (CNRA) in order to obtain new cultivars of palm seeds having lower concentrations of SFA compared to MUFA and PUFA.

Table 1
Rate of fatty acids (%)
Myristic acid Palmitic acid Stearic acid Satured fatty acids
Esterified cholesterol
J0 0.48± 0.40 20.95± 15.77 1.98 ± 1.54 23.42± 17.68
J7 0.43± 0.25 21.57± 14.64 2.59± 2.29 24.60± 16.71
J 15 0.51± 0.49 21.73± 16.14 2.09 ± 1.27 24.34± 17.85
J0 vs J7 (P) 0.008* 0.000** 0.009* 0.000**
J0 vs J 15 (P) 0.001* 0.000** 0.000** 0.000**
Phospholipids
J0 0.13± 0.08 29.76± 7.12 17.48± 3.87 47.39± 8.23
J7 0.21± 0.23 35.37± 7.34 19.51± 4.36 55.10± 11.60
J 15 0.21± 0.10 34.18± 5.56 18.77± 4.29 53.17± 6.33
J0 vs J7 (P) 0.180 0.943 0.332 0.538
J0 vs J 15 (P) 0.228 0.224 0.104 0.975
Triacylglycerols
J0 0.78± 0.90 25.79±3.88 5.69± 0.83 32.27± 4.27
J7 0.46± 0.29 26.39± 3.76 5.45± 1.17 32.31± 3.85
J 15 0.54± 0.39 28.20± 2.35 6.23± 0.99 34.98± 2.90
J0 vs J7 (P) 0.688 0.054 0.443 0.51
J0 vs J 15 (P) 0.274 0.403 0.006* 0.35
Total lipids
J0 0.41 ± 0.15 25.80 ± 6.37 8.31 ± 2.24 34.53 ± 8.61
J7 0.35 ± 0.11 23.89± 1.74 7.34± 0.70 31.68± 2.20
J 10 0.42 ± 0.20 25.80± 6.37 8.31± 2.24 32.12± 1.75
J0 vs J7 (P) 0.318 0.460 0.323 0.145
J0 vs J 15 (P) 0.946 0.578 0.258 0.007*

Rate of satured fatty acids in the different lipid fractions before and after supplementation

[i] * Significant ** Highly Significant

Table 2
Fatty acids rate (%)
Omega 6 Omega 3 Polyunsatured fatty acids ( PUFAs) Omega6/Omega 3
Esterified Cholesterol
J0 34.19± 5.29 4.84±1.59 43.09± 19.21 7.06
J7 33.25± 1.75 6.67± 3.97 40.90± 17.90 4.98
J 15 33.42± 1.90 5.96± 1.58 41.09± 17.66 5.60
J0 vs J7 ( P) 0.095 0.893 0.000** 0.316
J0 vs J 15 ( P) 0.267 0.930 0.000** 0.440
Phospholipids
J0 26.70± 5.69 6.66± 1.82 35.17± 2.07 4.00
J7 22.80± 9.06 6.14± 3.08 29.28± 11.58 3.71
J 15 23.71± 5.24 7.57± 3.44 31.60± 8.14 3.13
J0 vs J7 (P) 0.157 0.798 0.968 0.471
J0 vs J 15 (P) 0.036* 0.824 0.972 0.202
Triacylglycerols
J0 15.28± 3.91 1.88± 0.91 17.43± 4.73 8.12
J7 13.08± 3.05 1.79± 0.84 15.13± 3.82 7.30
J 15 13.36± 2.51 2.18± 1.37 15.75± 3.79 6.12
J0 vs J7 (P) 0.011* 0.049* 0.005* 0.429
J0 vs J 15 (P) 0.018* 0.187 0.039* 0.149
Total lipids
J0 34.19± 5.29 4.84± 1.59 39.27± 5,97 7.06
J7 33.25±1.75 6.67±3.97 40.15± 3,53 4.98
J 15 33.42± 1.90 5.96±1.58 39.58± 2,47 5.60
J0 vs J7 (P) 0.095 0.893 0.044* 0.316
J0 vs J 15 (P) 0.267 0.930 0.036* 0.440

Rate of polyunsatured fatty acids in the different lipid fractions before and after supplementation

[i] * Significant ** Highly Significant

Conclusion

Our study certainly highlighted on the incidence of crude palm oil on the incorporation and distribution of fatty acids in plasmatic lipids. We noted an augmentation of incorporation of SFA in the different lipid fractions together with the MUFA in the total lipids. Nonetheless, the consumption of crude palm oil revealed some benefit effects on the omega6/omega3 ratio which could be advantageous on the sustaining of health. Although, the impact of its consumption on the triggering of cardio-vascular diseases is not elucidated. Implementation of new cultivars poor in satured fatty acids and enrich in unsatured will enable to fulfill the needs of health of several populations in the world according to its wide consumption precisely in the low income countries.

Limitations

Two major difficulties have obviously impacted the quality of our results; these are the short length of the study and the size of our sample. It has been difficult to obtain the free agreement of participants as regards the condition of implementation of this study. Another study more framed and subsidized could help to draw accurate conclusions in order to adjust our sights about palm oil consumption and precisely crude palm oil.

Source of funding

None.

Conflict of interest

The authors stated that there is no conflict of interest.

References

1 

R M Krauss R H Eckel B Howard A statement for healthcare professionals from the Nutrition Committee of the American Heart AssociationJ Nutr2001131132178

2 

National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)JAMA2001285248697

3 

A A Mond F Michel M A Carbonneau G Tiahou M H Vernet Duvernay-Eymard S. Fatty acid and antioxidant contents of palm oil of Cte dIvoirePharmacope et Mdecine Traditionnelle Africaines2008151117

4 

S Vega-Lopez L M Ausman S M Jalbert A T Erkkila A H Lichtenstein Palm and partially hydrogenated soybean oils adversely alter lipoprotein profiles compared with soybean and canola oilsAm J Clin Nutr2006845462

5 

A A Monde F Michel M A Carbonneau Comparative study of fatty acid composition, vitamin E and carotenoid contents of palm oils from four varieties of oil palm from Cte DIvoireJ Sci Food Agric20098925352540

6 

Stress oxydant et dficit en slnium : Potentiel rle antioxydant de lhuile de palme bruteAm J Clin Nutr200377114655

7 

I Pons A I Castellote Lpez-Sabater Mc Comparison of conventional and fast gas chromatography in human plasma fatty acid determinationJ Chromatogr B Analyt Technol Biomed Life Sci2004809339383

8 

K Sundram R Sambanthamurthi Y A Tan Palm fruit chemistry and nutritionAsia Pac J Clin Nutr200312335562

9 

J Mayneris-Perxachs Plasma fatty acid composition, estimated desaturase activities, and their relation with the metabolic syndrome in a population at high risk of cardiovascular diseaseClinical Nutrition201310.1016/j.clnu.2013.03.001

10 

J M Lecerf Lhuile de palme : aspects nutritionnels et mtaboliques. Rle sur le risque cardiovasculaireOCL2013203147159

11 

P T Voon Tkw Ng Vkm Lee K Nesaretnam Diets high in palmitic acid (16:0), lauric and myristic acids (12:0 + 14:0), or oleic acid (18:1) do not alter postprandial or fasting plasma homocysteine and inammatory markers in healthy malaysian adultsAm J Clin Nutr20119414511458

12 

R P Mensink L Peter - Zock D M Arnold - Kester - Martijn B Katan Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trialsAm J Clin Nutr200377114655

13 

J I Pedersen H Muller I Seljeot B Kirkhus Palm oil versus hydrogenated soybean oil: effects on serum lipids and plasma haemos- tatic variablesAsia Pac J Clin Nutr20051434857

14 

A Astrup J Dyerberg P Elwood the role of reducing intakes of satured fat in the prevention of cardiovascular disease. Where does the evidence stand in 2010?Am J Clin Nutr201193684688

15 

P W Siri-Tarino Sun Qi B Hu M R Krauss Satured fat, carbohydrate, and cardiovascular diseaseAm J Clin Nutr201091502511

16 

J Zhang H Kestelot differences in all-cause cardiovascular and cancer mortality between Hong Kong and Singapour: role of nutritionEur J Epidemiol20011746977

17 

E K Kabagambe A Baylin A Ascherio H Campos The type of oil used for cooking is associated with the risk of nonfatal acute myocardial infarction in costa ricaJ Nutr20051351126742683

18 

G Zhennan Janel S C Haiqin Yong Qc Mecanisms of omega-3 polyunsatured fatty acids in prostate cancer preventionBioMed Res Int2013

19 

P M Kris-Etherton K D Hecker A E Binkoski Polyunsaturated fatty acids and cardiovascular healthNutr Rev20046211414440

20 

T Tholstrup P Marckmann B Vessby B Sandstrm Effects of fats high in individual saturated fatty acids on plasma lipoprotein (a) levels in young healthy menJ Lip Res199536144752

21 

D Y Oh S Talukdar E J Bae GPR120 is an Omega- 3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effectsCell20101425687698

22 

P Legrand J M Bourre B Descomps G Durand S Renaud Martin A. ed Lavoisier Tec Doc . Apports nutritionnels conseills pour la population franaise20016382

23 

T Yamashita Oda E Sano T . Varying the ratio of dietary n-6/n-3 polyunsaturated fatty acid alters the tendency to thrombosis and progress of atherosclerosis in apoE-/- LDLR-/- double knockout mouseThromb Res2005116393401

24 

H-Q Liu Y Qiu Y Mu A high ratio of dietary n-3/n-6 polyunsaturated fatty acids improves obesity-linked inflammation and insulin resistance through suppressing activation of TLR4 in SD ratsNutr Res201333849858

25 

T Burns S R Maciejewski W R Hamilton M Zheng A N Mooss D E Hilleman Effect of omega-3 fatty acid supplementation on the arachidonic acid:eicosapentaenoic acid ratioPharmacother200727633638

26 

Y A Tan R Sambanthamurthi K Sundram M B Wahid Valorisation of palm by-products as functional componentsEur J Lipid SciTechnol2007109380393

27 

E E Lohoues T Latte Y F Djohan H F Yapi E D Sess Dtermination de paramtres de la lipoperoxydation et de lathrosclrose dans deux populations en Cte dIvoireCah Sant Publique2007615662



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Article type

Original Article


Article page

283-288


Authors Details

DERE Kwadjo Anicet Luc, DJOHAN Youzan Ferdinand, MANHAN Kahissi´e, KOUAME Andr´e Bhellis, TIAHOU Gno


Article Metrics


View Article As

 


Downlaod Files